Position in JNJ
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$13,253,170
+$568,446 QoQ
Shares Held
52,184
+0.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.15%
of 13F equity value
Holder Rank
#946
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NAPLES GLOBAL ADVISORS, LLC holds $87,787,212 across 12 Drug Manufacturers - General names. JNJ ranks #3 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
12,798 | $15,350,306 | |
| 2 | MRK |
Merck & Co., Inc.
|
106,535 | $13,689,747 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
52,184 | $13,253,170 | |
| 4 | AMGN |
Amgen Inc
|
35,170 | $12,735,760 | |
| 5 | ABBV |
AbbVie Inc.
|
48,122 | $12,109,420 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
89,358 | $5,148,807 | |
| 7 | AZN |
Astrazeneca PLC
|
24,721 | $4,687,596 | |
| 8 | NVS |
Novartis AG
|
26,087 | $4,088,354 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,253,170 | 52,184 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $12,684,724 | 51,893 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $10,333,841 | 49,934 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $9,238,922 | 49,827 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $7,395,238 | 48,414 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $7,754,512 | 46,759 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $6,662,643 | 46,070 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $7,378,753 | 45,531 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $6,524,290 | 44,638 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $7,030,754 | 44,445 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $6,752,672 | 43,082 | Shares | Sole | 2024-01-11 | |
| 2023-09-30 | $6,712,202 | 43,096 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $6,879,838 | 41,565 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $5,555,510 | 35,842 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $6,110,676 | 34,592 | Shares | Sole | 2023-04-17 | |
| 2022-09-30 | $5,668,428 | 34,699 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $5,717,597 | 32,210 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $5,574,415 | 31,453 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $5,290,339 | 30,925 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $4,842,254 | 29,983 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $4,906,945 | 29,786 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $4,652,748 | 28,310 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $4,196,222 | 26,663 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $4,134,546 | 27,771 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $3,659,895 | 26,025 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $3,411,084 | 26,013 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||